A pathway designed to streamline cancer diagnoses for people whose symptoms fall outside usual guidelines helped detect the disease or other serious conditions in almost one in five patients.

The study, published today in the Lancet Primary Care, tracked over 4,800 patients referred to the SCAN Pathway between 2017 and 2023. SCAN was originally developed in Oxfordshire in partnership with ...

A major UK study has provided the most comprehensive analysis to date of a cancer diagnosis pathway for patients presenting with non-specific symptoms (NSS), such as unexplained weight loss or fatigue ...